Yap JT - Search Results

1

On-line measurement of exhaled [11C]CO2 during PET.

Gunn RN, Ranicar A, Yap JT, Wells P, Osman S, Jones T, Cunningham VJ. Gunn RN, et al. Among authors: yap jt. J Nucl Med. 2000 Apr;41(4):605-11. J Nucl Med. 2000. PMID: 10768560 Free article.

2

A general method to correct PET data for tissue metabolites using a dual-scan approach.

Gunn RN, Yap JT, Wells P, Osman S, Price P, Jones T, Cunningham VJ. Gunn RN, et al. Among authors: yap jt. J Nucl Med. 2000 Apr;41(4):706-11. J Nucl Med. 2000. PMID: 10768573 Free article.

3

Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug action.

Saleem A, Yap J, Osman S, Brady F, Suttle B, Lucas SV, Jones T, Price PM, Aboagye EO. Saleem A, et al. Lancet. 2000 Jun 17;355(9221):2125-31. doi: 10.1016/s0140-6736(00)02380-1. Lancet. 2000. PMID: 10902627 Clinical Trial.

4

Measurement of renal tumour and normal tissue perfusion using positron emission tomography in a phase II clinical trial of razoxane.

Anderson H, Yap JT, Wells P, Miller MP, Propper D, Price P, Harris AL. Anderson H, et al. Among authors: yap jt. Br J Cancer. 2003 Jul 21;89(2):262-7. doi: 10.1038/sj.bjc.6601105. Br J Cancer. 2003. PMID: 12865914 Free PMC article. Clinical Trial.

5

Assessment of pharmacodynamic vascular response in a phase I trial of combretastatin A4 phosphate.

Anderson HL, Yap JT, Miller MP, Robbins A, Jones T, Price PM. Anderson HL, et al. Among authors: yap jt. J Clin Oncol. 2003 Aug 1;21(15):2823-30. doi: 10.1200/JCO.2003.05.186. Epub 2003 Jun 13. J Clin Oncol. 2003. PMID: 12807935 Clinical Trial.

6

Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurements with 15O-labeled water and PET.

Kaufmann PA, Gnecchi-Ruscone T, Yap JT, Rimoldi O, Camici PG. Kaufmann PA, et al. Among authors: yap jt. J Nucl Med. 1999 Nov;40(11):1848-56. J Nucl Med. 1999. PMID: 10565780 Free article.

7

PET/CT today and tomorrow.

Townsend DW, Carney JP, Yap JT, Hall NC. Townsend DW, et al. Among authors: yap jt. J Nucl Med. 2004 Jan;45 Suppl 1:4S-14S. J Nucl Med. 2004. PMID: 14736831 Free article. Review.

8

Summary of the UPICT Protocol for 18F-FDG PET/CT Imaging in Oncology Clinical Trials.

Graham MM, Wahl RL, Hoffman JM, Yap JT, Sunderland JJ, Boellaard R, Perlman ES, Kinahan PE, Christian PE, Hoekstra OS, Dorfman GS. Graham MM, et al. Among authors: yap jt. J Nucl Med. 2015 Jun;56(6):955-61. doi: 10.2967/jnumed.115.158402. Epub 2015 Apr 16. J Nucl Med. 2015. PMID: 25883122 Free PMC article.

9

Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

Shankar LK, Hoffman JM, Bacharach S, Graham MM, Karp J, Lammertsma AA, Larson S, Mankoff DA, Siegel BA, Van den Abbeele A, Yap J, Sullivan D; National Cancer Institute. Shankar LK, et al. J Nucl Med. 2006 Jun;47(6):1059-66. J Nucl Med. 2006. PMID: 16741317 Free article. No abstract available.

10

ACRIN 6665/RTOG 0132 phase II trial of neoadjuvant imatinib mesylate for operable malignant gastrointestinal stromal tumor: monitoring with 18F-FDG PET and correlation with genotype and GLUT4 expression.

Van den Abbeele AD, Gatsonis C, de Vries DJ, Melenevsky Y, Szot-Barnes A, Yap JT, Godwin AK, Rink L, Huang M, Blevins M, Sicks J, Eisenberg B, Siegel BA. Van den Abbeele AD, et al. Among authors: yap jt. J Nucl Med. 2012 Apr;53(4):567-74. doi: 10.2967/jnumed.111.094425. Epub 2012 Mar 1. J Nucl Med. 2012. PMID: 22381410 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters